APO-CYCLOBENZAPRINE 10 MG
CYCLOBENZAPRINE HYDROCHLORIDE : 10 MG · DIN 02177145 · APOTEX INC
Health Canada status: MARKETED
What is APO-CYCLOBENZAPRINE?
APO-CYCLOBENZAPRINE 10 MG contains CYCLOBENZAPRINE HYDROCHLORIDE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02177145, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 18-Jun-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-CYCLOBENZAPRINE used for?
APO-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride) is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Cyclobenzaprine should be used only for short periods (up to two or three weeks), because adequate evidence of effectiveness for more prolonged use is not available, and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02177145 |
|---|---|
| Brand name | APO-CYCLOBENZAPRINE |
| Generic / active ingredient | CYCLOBENZAPRINE HYDROCHLORIDE : 10 MG |
| Manufacturer | APOTEX INC |
| Strength | 10 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | M03BX08 CYCLOBENZAPRINE |
| AHFS class | 12:20.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 18-Jun-2021 |
| Original market date | 1995-12-31 00:00:00 |
How is it stored and handled?
Preserve in well-closed containers at room temperature 15°C to 30°C.
How is it supplied?
Bottles of 100, 250, 500 and 1000 tablets
Is CYCLOBENZAPRINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code M03BX08 CYCLOBENZAPRINE. 10 of 23 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-CYCLOBENZAPRINE | 10 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02485419 |
| AURO-CYCLOBENZAPRINE | 10 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02348853 |
| CYCLOBENZAPRINE | 10 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02424584 |
| CYCLOBENZAPRINE | 10 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02287064 |
| JAMP-CYCLOBENZAPRINE | 10 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02357127 |
| PMS-CYCLOBENZAPRINE - TAB 10MG | 10 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02212048 |
| PRO-CYCLOBENZAPRINE | 10 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02220644 |
| RIVA-CYCLOBENZAPRINE | 10 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED | DIN 02242079 |
| TEVA-CYCLOBENZAPRINE | 10 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02080052 |
| ALTI-CYCLOBENZAPRINE - TAB 10MG | 10 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02174618 |
Who else supplies CYCLOBENZAPRINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CYCLOBENZAPRINE appears in 17 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.